iSpecimen Inc Logo
US45032V2079

iSpecimen Inc

Cargando cotizaciones...

Previsión

Comprar
  2
Mantener
  0
Vender
  0

  • iSpecimen settles dispute with WestPark Capital by paying $97,500

    iSpecimen reached a settlement agreement with WestPark Capital and will pay $97,500 to resolve all claims arising from prior investment banking engagements and an arbitration. WestPark had originally sought $269,999.91 plus interest and costs; the settlement is not an admission of liability. iSpecimen expects to record the payment as an expense in the quarter ended September 30, 2026. The company also reported the closing of a $2.5 million private placement with E.F. Hutton as placement agent. » Más en de.investing.com

Datos financieros de la empresa

En el último trimestre, iSpecimen Inc tuvo unos ingresos de 133,13 mil € y un beneficio neto de -1,19 M €
(EUR) jun 2026
YoY
Ingresos 133,13 mil 78,00 %
Beneficio bruto -116,37 mil 151,00 %
Beneficio neto -1,19 M 34,40 %
EBITDA -1,02 M 95,21 %

Datos fundamentales

Métrica Valor
Capitalización bursátil
191,84 mil €
Número de acciones
138,86 mil
Máximo/mínimo de 52 semanas
109,83 € - 1,21 €
Dividendos No
Beta
1,64
Ratio P/E
-0,03
Ratio PEG
0,00
Ratio P/B
1,28
Ratio P/S
0,48

Perfil de la empresa

Nombre
iSpecimen Inc
CEO
Katharyn Field
Empleados 7
🍪

Parqet  usa cookies. Más información